Quick Answer
Sensus Healthcare, Inc. reported R&D Expense of $7.78 million for fiscal year 2025.
Sensus Healthcare, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $7.78M | +84.5% |
| 2024 | $4.22M | +14.6% |
| 2023 | $3.68M | +6.3% |
| 2022 | $3.46M | +0.7% |
| 2021 | $3.44M | -17.4% |
| 2020 | $4.16M | -35.2% |
| 2019 | $6.42M | +2.5% |
| 2018 | $6.26M | +14.0% |
| 2017 | $5.49M | +201.0% |
| 2016 | $1.82M | +24.4% |
| 2015 | $1.47M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.82M | +110.8% | +23.7% |
| June 30, 2025 | $1.47M | +69.9% | -43.6% |
| March 31, 2025 | $2.61M | +181.4% | +202.0% |
| September 30, 2024 | $863.0K | -20.3% | -0.3% |
| June 30, 2024 | $866.0K | +5.4% | -6.5% |
| March 31, 2024 | $926.0K | -15.7% | -14.5% |
| September 30, 2023 | $1.08M | +45.2% | +31.8% |
| June 30, 2023 | $822.0K | -0.6% | -25.1% |
- Sensus Healthcare, Inc. showed an increase of +84.5% in R&D Expense compared to the prior fiscal year.
- Over the 2015–2025 period, Sensus Healthcare, Inc.’s r&d expense has grown by 430.3% (from $1.47 million to $7.78 million).
- The most recent figure is from Sensus Healthcare, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: